Development of Antibiotic Activity Profile Screening for the Classification and Discovery of Natural Product Antibiotics

被引:74
作者
Wong, Weng Ruh [1 ,2 ]
Oliver, Allen G. [3 ]
Linington, Roger G. [1 ]
机构
[1] Univ Calif Santa Cruz, Dept Chem & Biochem, Santa Cruz, CA 95064 USA
[2] Fed Govt Adm Ctr, Minist Sci Technol & Innovat Malaysia, Putrajaya 62662, Malaysia
[3] Univ Notre Dame, Dept Chem & Biochem, Mol Struct Facil, Notre Dame, IN 46556 USA
来源
CHEMISTRY & BIOLOGY | 2012年 / 19卷 / 11期
基金
美国国家科学基金会;
关键词
EVOLVING TRENDS; DRUG DISCOVERY; BAD BUGS; IDENTIFICATION; DEREPLICATION; RESISTANCE; EXTRACTS; BACTERIA; NMR;
D O I
10.1016/j.chembiol.2012.09.014
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Despite recognition of the looming antibiotic crisis by healthcare professionals, the number of new antibiotics reaching the clinic continues to decline sharply. This study aimed to establish an antibiotic profiling strategy using a panel of clinically relevant bacterial strains to create unique biological fingerprints for all major classes of antibiotics. Antibiotic mode of action profile (BioMAP) screening has been shown to effectively cluster antibiotics by structural class based on these fingerprints. Using this approach, we have accurately predicted the presence of known antibiotics in natural product extracts and have discovered a naphthoquinone-based antibiotic from our marine natural product library that possesses a unique carbon skeleton. We have demonstrated that bioactivity fingerprinting is a successful strategy for profiling antibiotic lead compounds and that BioMAP can be applied to the discovery of new natural product antibiotics leads.
引用
收藏
页码:1483 / 1495
页数:13
相关论文
共 38 条
[1]   PENICILLINASE-RESISTANT PENCILLINS + CEPHALOSPORINS [J].
BARBER, M ;
WATERWORTH, PM .
BRITISH MEDICAL JOURNAL, 1964, 2 (540) :344-&
[2]   Minocycline-an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii [J].
Bishburg, Eliahu ;
Bishburg, Kathryn .
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2009, 34 (05) :395-401
[3]  
Blunt J.W., 2009, ANTIMARIN DATABASE
[4]   Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of America [J].
Boucher, Helen W. ;
Talbot, George H. ;
Bradley, John S. ;
Edwards, John E., Jr. ;
Gilbert, David ;
Rice, Louis B. ;
Scheld, Michael ;
Spellberg, Brad ;
Bartlett, John .
CLINICAL INFECTIOUS DISEASES, 2009, 48 (01) :1-12
[5]  
Chan P.F., 2004, DRUG DISCOV TODAY TH, V1, P519, DOI DOI 10.1016/J.DDSTR.2004.11.003
[6]   Fumaquinone, a new prenylated naphthoquinone from Streptomyces fumanus [J].
Charan, RD ;
Schlingmann, G ;
Bernan, VS ;
Feng, XD ;
Carter, GT .
JOURNAL OF ANTIBIOTICS, 2005, 58 (04) :271-274
[7]   Antibacterial Activity of Novel Naphthoquiones Derivatives [J].
Chung, Yongseog ;
Quan, Ren shu ;
Chang, Hyeon Mo ;
Kwon, Soo Han ;
Kim, Soon-Ja ;
Im, Young-Sam ;
Shin, Kyeong Seob ;
Park, Kyung-Do ;
Lee, Hak-Kyo ;
Choi, Joong-Kook .
GENES & GENOMICS, 2009, 31 (06) :429-434
[8]   New antibiotics from bacterial natural products [J].
Clardy, Jon ;
Fischbach, Michael A. ;
Walsh, Christopher T. .
NATURE BIOTECHNOLOGY, 2006, 24 (12) :1541-1550
[9]   Open source clustering software [J].
de Hoon, MJL ;
Imoto, S ;
Nolan, J ;
Miyano, S .
BIOINFORMATICS, 2004, 20 (09) :1453-1454
[10]   DNA gyrase, topoisomerase IV, and the 4-quinolones [J].
Drlica, K ;
Zhao, XL .
MICROBIOLOGY AND MOLECULAR BIOLOGY REVIEWS, 1997, 61 (03) :377-+